home_image

Industrial Cell Culture

Quality products and custom services for bioprocessing needs.

Industrial Cell Culture Industrial Cell Culture

Best-in-class products and custom media services for industrial bioprocessing and cell culture applications.

home_image

Assisted Reproductive Technology

Renowned technology since 1986.

Assisted Reproductive Technology Assisted Reprod. Tech.

Foster life with Assisted Reproductive Technology products that produce consistent and reliable results.

home_image

Cytogenetics

The standard for excellence for optimal cell growth.

Cytogenetics Cytogenetics

Optimized media for the culture of human amniotic fluid, bone marrow, and blood cells.

home_image

Cell Therapy

Integrated workflow solutions for stem cells and primary cells.

Cell Therapy Cell Therapy

Providing validated products and custom media services for cell therapy and regenerative medicine applications.

news

Jun 4 | Fujifilm completes acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of

FUJIFILM Corporation (President: Kenji Sukeno) announced today that it has completed…

Mar 29 | JXTGE Announces Sale of Irvine Scientific to Fujifilm

SANTA ANA, California March 29, 2018: JXTG Nippon Oil & Energy…

See More News

events

XXII Brazilian Congress of Assisted Reproduction

Brasília, Brazil
August 01 - August 04, 2018

CGC Annual Meeting

Nashville, Tennessee USA
August 06 - August 08, 2018

See More Upcoming Events

Support Links

Lastest Posts

Behind the Scenes: What Factors Play a Role in High Quality IVF Media

Media developed to support ART applications play a crucial role in facilitating new life. When it comes to something so precious, it’s imperative the innovative tools you choose to work with have been subject…

Cohesive Control of Antibody Galactosylation for Improved Antibody Product Quality and Function

Protein-based therapeutics are dominating the pharmaceutical market due to their high-efficacy in treating complex diseases.1 The demand for antibody (Ab) drugs continues to rise…

See More Blog Posts

Recent Tweets